Erasto Gaertner Hospital
Erasto Gaertner Hospital
Senior Staff, Division of Gynecology Oncology, Erasto Gaertner Hospital, Curitiba, PR, Brazil. Research Director of the Gynecologic Oncology Division. Gynecology Oncology Fellowship Director. Robotic Training Program Director.

Moderator of 1 Session

Session Type
Surgical Films
Date
09/30/2022
Session Time
04:00 PM - 06:00 PM
Room
Hall 405
Session Icon
On-Demand
Session Description
The Complications Surgical Session has been created to help attendees gain a thorough understanding of surgical complications while learning how to safely mannage them during gynecologic oncology procedures. By joining this 2 hours session, standart lectures with tips and tricks will help attendees to reduce the chance of developing unwanted complications and enhance their skills to treat surgical complications. Also, the interactive cases discussions will explore different aproach to complications and enhance decision making, while the participants can vote on the aproach the like better.

Presenter of 5 Presentations

Closing Comments

Session Type
Surgical Films
Date
09/30/2022
Session Time
04:00 PM - 06:00 PM
Room
Hall 405
Session Icon
On-Demand
Lecture Time
05:55 PM - 06:00 PM
Onsite or Pre-Recorded
Onsite

Anatomical principles of flap surgery for gynae oncologists: perineum, vulva, vagina

Session Type
Surgical Films
Date
10/01/2022
Session Time
02:35 PM - 03:50 PM
Room
Hall 501
Session Icon
Live
Lecture Time
03:22 PM - 03:37 PM
Onsite or Pre-Recorded
Onsite

Management of vascular complications

Session Type
Surgical Films
Date
09/30/2022
Session Time
04:00 PM - 06:00 PM
Room
Hall 405
Session Icon
On-Demand
Lecture Time
05:00 PM - 05:20 PM
Onsite or Pre-Recorded
Onsite

• Successful pregnancy following uterine transposition

Session Type
Surgical Films
Date
09/29/2022
Session Time
01:55 PM - 03:55 PM
Room
Hall 405
Session Icon
On-Demand
Lecture Time
03:15 PM - 03:25 PM
Onsite or Pre-Recorded
Onsite

UTERINE TRANSPOSITION: FEASIBILITY STUDY

Session Type
Plenary Session
Date
09/29/2022
Session Time
08:00 AM - 10:30 AM
Room
Hall 501
Session Icon
Live
Lecture Time
08:25 AM - 08:33 AM
Onsite or Pre-Recorded
Onsite

Abstract

Objectives

To evaluate the feasibility of uterine transposition (UT) as a method of preserving ovarian and uterine function after pelvic radiation.

Methods

This was a prospective, non-randomized feasibility study of UT for patients with non-gynecologic pelvic cancers, who require radiation. UT to the upper abdomen was performed 7 to 14 days prior radiation. Frequent clinical examinations and doppler ultrasound were used to evaluate the gonadal vessels vasculature after surgery. The uterus was placed back to the pelvis 2 to 4 weeks after radiation and patients were followed with clinical examinations, pelvic ultrasound and laboratory tests to evaluate hormonal function. Menses were systematically recorded. Cancer treatment and follow-up were performed according to the standard guidelines and no modification were allowed.

Results

From June 2017 to June 2019, eleven patients were selected for the study. Eight patients were submitted to UT (median age of 30.5 yo). There were no transoperatory complications. Cervical stenosis was the most common postoperative complication. One patient had uterine necrosis 4 days after surgery, but the right ovary was preserved and kept normal hormonal function. One patient died from carcinomatosis 4 months after UT. All patients who preserved the uterus have normal hormonal levels, menses and sexual activity after treatment. Two patients have had spontaneous pregnancies, one baby was born at 37 weeks and the other patient is 20 weeks pregnant. One patient tried to get pregnant but did not succeed.

Conclusions

Uterine transposition is a feasible procedure to preserve the uterus and gonadal function. Spontaneous and healthy pregnancy is also possible.

Hide